MedTrace Logo

Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty

NCT03859024 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

The investigator's study aims to see if an enhanced recovery regimen of pain medications before and during surgery will decrease the use and risk of opioid pain medications as well as improve pain control in anterior urethroplasty patients. Participants will be randomized to one of two pain regimens (enhanced recovery regimen vs standard regimen).

Conditions

  • Pain, Postoperative
  • Urethral Stricture

Interventions

DRUG

Oxycodone

oxycodone tablet

DRUG

Acetaminophen

acetaminophen tablet

DRUG

Gabapentin

gabapentin tablet

DRUG

celebrex

Celebrex tablet

DRUG

Bupivacaine

bupivacaine injection

DRUG

Ibuprofen 800 mg

ibuprofen tablet

DRUG

Dexamethasone

Dexamethasone injection

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • John P Selph, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-22
Primary Completion
2023-04-30
Completion
2023-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03859024 on ClinicalTrials.gov